NOS2 and colitis: Doxycycline contributed by limiting neutrophil activation and reducing iNOS expression, consistent with previous findings demonstrating its ability to decrease nitrite production in LPS-stimulated RAW 264.7 macrophages and in experimental colitis models (DSS and TNBS), including in association with probiotics [21].